Tess V. Dupre

432 total citations
13 papers, 322 citations indexed

About

Tess V. Dupre is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Tess V. Dupre has authored 13 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Molecular Biology. Recurrent topics in Tess V. Dupre's work include Chemotherapy-induced organ toxicity mitigation (7 papers), Acute Lymphoblastic Leukemia research (3 papers) and Biomedical Research and Pathophysiology (3 papers). Tess V. Dupre is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (7 papers), Acute Lymphoblastic Leukemia research (3 papers) and Biomedical Research and Pathophysiology (3 papers). Tess V. Dupre collaborates with scholars based in United States. Tess V. Dupre's co-authors include Leah J. Siskind, Levi J. Beverly, Parag P. Shah, Judit Megyesi, Cierra N. Sharp, Mark A. Doll, Deanna Siow, Gavin E. Arteel, Rick G. Schnellmann and Rick G. Schnellmann and has published in prestigious journals such as The FASEB Journal, American Journal Of Pathology and Journal of Lipid Research.

In The Last Decade

Tess V. Dupre

12 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tess V. Dupre United States 10 141 129 85 34 33 13 322
Cibele S. Pinto United States 10 273 1.9× 73 0.6× 67 0.8× 18 0.5× 17 0.5× 16 404
Claus D. Schuh Switzerland 9 120 0.9× 55 0.4× 97 1.1× 51 1.5× 10 0.3× 10 360
Asako Hayashi Japan 9 231 1.6× 50 0.4× 76 0.9× 23 0.7× 57 1.7× 26 407
Jelle Vriend Netherlands 8 145 1.0× 40 0.3× 43 0.5× 24 0.7× 32 1.0× 11 344
Charles McKay United States 7 235 1.7× 43 0.3× 70 0.8× 15 0.4× 67 2.0× 17 401
Anthony W. Norman United States 12 171 1.2× 280 2.2× 32 0.4× 23 0.7× 29 0.9× 22 467
Kate Witkowska Canada 5 161 1.1× 40 0.3× 62 0.7× 14 0.4× 16 0.5× 8 338
Aurore Devocelle France 12 134 1.0× 37 0.3× 42 0.5× 48 1.4× 175 5.3× 15 488

Countries citing papers authored by Tess V. Dupre

Since Specialization
Citations

This map shows the geographic impact of Tess V. Dupre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess V. Dupre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess V. Dupre more than expected).

Fields of papers citing papers by Tess V. Dupre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tess V. Dupre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess V. Dupre. The network helps show where Tess V. Dupre may publish in the future.

Co-authorship network of co-authors of Tess V. Dupre

This figure shows the co-authorship network connecting the top 25 collaborators of Tess V. Dupre. A scholar is included among the top collaborators of Tess V. Dupre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tess V. Dupre. Tess V. Dupre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dupre, Tess V., Parag P. Shah, Mark A. Doll, et al.. (2022). Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. Journal of Lipid Research. 63(3). 100179–100179. 11 indexed citations
2.
Dupre, Tess V., Rick G. Schnellmann, & Gary W. Miller. (2020). Using the exposome to address gene–environment interactions in kidney disease. Nature Reviews Nephrology. 16(11). 621–622. 8 indexed citations
3.
Dupre, Tess V., et al.. (2019). The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells. Biochemical Pharmacology. 169. 113644–113644. 25 indexed citations
4.
Cameron, Robert B., Whitney S. Gibbs, Tess V. Dupre, et al.. (2019). Proximal Tubule β2-Adrenergic Receptor Mediates Formoterol-Induced Recovery of Mitochondrial and Renal Function after Ischemia-Reperfusion Injury. Journal of Pharmacology and Experimental Therapeutics. 369(1). 173–180. 29 indexed citations
5.
Barati, Michelle T., Tess V. Dupre, Kenneth B. Gagnon, et al.. (2019). Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury. American Journal Of Pathology. 189(6). 1190–1200. 6 indexed citations
6.
Dupre, Tess V. & Leah J. Siskind. (2018). The role of sphingolipids in acute kidney injury. Advances in Biological Regulation. 70. 31–39. 14 indexed citations
7.
Sharp, Cierra N., Mark A. Doll, Tess V. Dupre, Levi J. Beverly, & Leah J. Siskind. (2018). Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration. American Journal of Physiology-Renal Physiology. 316(1). F162–F172. 13 indexed citations
8.
Dupre, Tess V., Mark A. Doll, Parag P. Shah, et al.. (2017). Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. Journal of Lipid Research. 58(7). 1439–1452. 41 indexed citations
9.
Shah, Parag P., Tess V. Dupre, Leah J. Siskind, & Levi J. Beverly. (2017). Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress. Oncotarget. 8(14). 22625–22639. 48 indexed citations
10.
Dupre, Tess V., Mark A. Doll, Parag P. Shah, et al.. (2016). Suramin Protects From Cisplatin‐Induced Acute Kidney Injury. The FASEB Journal. 30(S1).
11.
Sharp, Cierra N., Mark A. Doll, Tess V. Dupre, et al.. (2016). Repeated administration of low-dose cisplatin in mice induces fibrosis. American Journal of Physiology-Renal Physiology. 310(6). F560–F568. 93 indexed citations
12.
Dupre, Tess V., Mark A. Doll, Parag P. Shah, et al.. (2015). Suramin protects from cisplatin-induced acute kidney injury. American Journal of Physiology-Renal Physiology. 310(3). F248–F258. 25 indexed citations
13.
Zeiderman, Matthew, Michael E. Egger, Charles W. Kimbrough, et al.. (2014). Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. Journal of Surgical Research. 190(1). 111–118. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cibele S. Pinto Breakdown of academic impact, for papers by Claus D. Schuh Breakdown of academic impact, for papers by Asako Hayashi Breakdown of academic impact, for papers by Jelle Vriend Breakdown of academic impact, for papers by Charles McKay Breakdown of academic impact, for papers by Anthony W. Norman Breakdown of academic impact, for papers by Kate Witkowska Breakdown of academic impact, for papers by Aurore Devocelle
Rankless by CCL
2026